About
Pharmadva is also known as Medacube. MedaCube is an innovative medical device developed and patented at the University of Rochester Medical Center (URMC) to address the critical challenge of medication adherence. Designed to serve third-party payers, healthcare providers, pharmacies, medical monitoring companies, and families, MedaCube supports improved health outcomes and independent living for aging individuals. Validated through clinical trials at the SJFC Wegmans School of Pharmacy under URMC IRB since 2015, MedaCube has demonstrated industry-leading results. Now commercially available, it is at the heart of PharmAdva’s mission to solve the $300 billion annual medication adherence problem in the U.S.
RochesterManufacturing